학술논문

Phase II clinical trial of liposomal-encapsulated doxorubicin citrate and docetaxel, associated with trastuzumab, as neoadjuvant treatment in stages II and IIIA HER2-overexpressing breast cancer patients. GEICAM 2003-03 study
Document Type
Article
Source
In Annals of Oncology January 2011 22(1):74-79
Subject
Language
ISSN
0923-7534